This is the authors' abstract. We don't add key points for this paper.
A series of lithium complexes were prepared from 2(N-piperazinyl-N'-methyl)-2-methylene-4-R'-6-R-phenols ([ONN](RR')) and characterized through elemental analysis, (1)H and (13)C{(1)H} NMR spectroscopy, and X-ray crystallography. Treatment of the ligands with n-butyllithium afforded {Li[ONN](RR')}(3) [R = Me, R' = (t)Bu, (1); R = R' = (t)Bu (2); R = R' = (t)Am, (3), (t)Am = C(CH(3))(2)CH(2)CH(3)], with trimetallic structures in the solid-state as shown by single-crystal X-ray diffraction. The reactivity of these complexes in the ring-opening polymerization of ε-caprolactone (ε-CL), as well as the influences of monomer concentration, monomer/Li molar ratio, polymerization temperature and time, was studied. Rates of polymerization were first order with respect to both monomer and lithium concentrations, and activation energies for the reactions were determined. MALDI-TOF MS analysis revealed that transesterification had occurred during the polymerization.
No takes yet. Share an insight, caveat, or question.
Ikpo et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: